Evidence map›Paper›PMID 19228019›Full record

ArticleMolecular pharmaceutics

Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

Leena N Patel, Jeffrey Wang, Kwang-Jin Kim, Zea Borok, Edward D Crandall, Wei-Chiang Shen

Abstract read
In one paragraph

Article in Molecular pharmaceutics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Preventing Protein Self-Association Through Strategic Covalent Modification.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. A review of lipidation in the development of advanced protein and peptide therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Leena N PatelDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, Will Rogers Institute Pulmonary Research Center, Keck School of Medicine, University of Southern California, Los Angeles, California 90089-9121, USA.
Jeffrey Wang
Kwang-Jin Kim
Zea Borok
Edward D Crandall
Wei-Chiang Shen
Rogers (United States) · USWestern University of Health Sciences · USUniversity of Southern California · US

Funding

Role of ATI cells in alveolar epithelial ion transportR01HL038621 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CRANDALL, EDWARD DAVID · 1986 to 2010
$3.2M
Transferrin Conjugates for Oral Protein Drug DeliveryR01GM063647 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHEN, WEI-CHIANG · 2002 to 2014
$3.0M
Role of FoxP2 in AEC (trans)differentiationR01HL062569 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2000 to 2008
$2.8M
Molecular programming of AEC differentiation: role of forkhead factorsR37HL062569 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2010 to 2014
$2.2M
REGULATION OF ALVEOLAR EPITHELIAL CELL DIFFERENTIATIONR01HL038578 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI BOROK, ZEA · 1986 to 2007
$1.7M
Regulation of lung alveolar epithelial protein transportR01HL038658 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI KIM, KWANG-JIN · 1989 to 2005
$1.4M
Membrane Transduction Peptides for Drug DeliveryR01GM070777 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHEN, WEI-CHIANG · 2005 to 2008
$1.0M
LUNG EPITHELIAL TRANSPORT PROPERTIES AND ALVEOLAR EDEMAR37HL038578 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CRANDALL, EDWARD DAVID · 1987 to 1996
–
NHLBI NIH HHS HL038578NHLBI NIH HHS HL038621NHLBI NIH HHS HL038658NHLBI NIH HHS HL062569NHLBI NIH HHS HL064635NHLBI NIH HHS R01 HL038578NHLBI NIH HHS R01 HL038621NHLBI NIH HHS R01 HL038658NHLBI NIH HHS R01 HL062569NHLBI NIH HHS R37 HL062569NIGMS NIH HHS GM070777NIGMS NIH HHS R01 GM063647NIGMS NIH HHS R01 GM070777
6 · The paper itself

Abstract

In this study, we determined if cell-penetrating peptides (CPPs) can be used to enhance the absorption rate of insulin (INS) across the alveolar epithelial barrier. Using a heterobifunctional cross-linker, INS was conjugated to a series of cationic CPPs, including Tat peptide, oligoarginine (r9) or oligolysine (k9), via disulfide bridge to a D-isoform cysteine (c) present at the N-terminal of the peptide sequence, yielding INS-cTat, INS-cr9, and INS-ck9, respectively. SDS-PAGE and MALDI-TOF mass spectroscopy confirmed homogeneous conjugates with a 1:1 ratio of INS and various CPPs. Transport of INS and INS-CPPs across primary cultured rat alveolar epithelial cell monolayers was in the order INS-cr9 > INS-cTat > INS-ck9 > INS, with 27-, 19- and 4-fold increase compared to native INS, respectively. Transport of INS-cr9 was temperature- and time-dependent. Covalent conjugation between r9 and INS, as opposed to adding unconjugated INS and r9 together into donor fluid, was necessary to enhance transport of INS. Absorption of INS-cr9 across the alveolar epithelial barrier appeared to be in part transcellular, since INS-cr9 transport in the presence of heparin and protamine was decreased by approximately 20%. Adsorptive transcytosis appeared to be in part responsible for INS-cr9 absorption, as INS-cr9 did not compete with free INS in binding assays for INS receptors. Finally, intratracheal instillation of INS-cr9 in diabetic rats resulted in a steady decrease in blood glucose level that was more sustained over time when compared with INS. These results suggest that oligoarginine can be used to increase the alveolar absorption rate of insulin (and potentially other macromolecules as well).

Indexed as

AnimalsCarcinoma, HepatocellularCells, CulturedDiabetes Mellitus, ExperimentalEndocytosisEpithelial CellsHumansHypoglycemic AgentsInsulinLiver NeoplasmsPulmonary AlveoliRatsRats, Sprague-DawleyReceptor, InsulinRecombinant ProteinsHypoglycemic AgentsInsulinReceptor, InsulinRecombinant Proteins

Identifiers

PMID19228019
PMCPMC2798810
OpenAlexW1990554984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.